# Project Execution Status

## ✅ Completed Steps

### Phase 1: Data Acquisition & Integration
- ✅ **Data Availability Check**: All required datasets confirmed available
  - GSE122897 (RNA-seq): Available
  - GSE159610 (Blood RNA-seq): Available  
  - GWAS data (Bakker 2020): Available
  - Supplementary ZIP files: Extracted
  - TAR files: All 4 datasets available (GSE186927, GSE13353, GSE54083, GSE75436)
  - PDF files: Extracted and processed

- ✅ **Supplementary Data Integration**: Completed
  - GSE26969 metadata created
  - Supplementary tables extracted (9 sheets from Excel)
  - PDF data extracted (Maas et al. 2025 single-cell atlas)
  - Dataset inventory created

### Phase 2: Polygenic Risk Score Development
- ✅ **PRS Built**: Successfully completed
  - 17 risk loci identified from GWAS
  - PRS weights file created: `results/prs_weights.tsv`
  - Ready for genotype data integration

### Phase 3: Blood Transcriptomics Integration
- ⏳ **In Progress**: Blood integration script running (may take time)

## 📋 Remaining Steps

### Phase 3: Blood Transcriptomics Integration (Continue)
- Complete blood signature finalization
- Blood-tissue cross-dataset integration
- Validate signature performance

### Phase 4: Endothelial Dysfunction Profiling
- Analyze EC-specific dysfunction markers
- Integrate with blood signatures
- Generate EC dysfunction scores

### Phase 5: Multi-Omics Integration
- Combine PRS + Blood RNA + EC dysfunction + Clinical
- Train gradient boosting model
- SHAP interpretation
- Generate integrated risk scores

### Phase 6: Pathway Enrichment
- Run pathway enrichment analysis
- Identify enriched biological pathways
- Cross-validate with literature

### Phase 7: Comprehensive Integration
- Integrate all findings
- Create prioritized gene lists
- Generate comprehensive summary reports

## 📊 Generated Output Files

### Completed
- `results/gse122897_integrated_de.tsv` - RNA-seq differential expression
- `results/gse122897_top_genes_integrated.tsv` - Top significant genes
- `results/prs_weights.tsv` - PRS weights for 17 risk loci
- `results/gse26969_metadata.tsv` - Microarray metadata
- `results/dataset_inventory.json` - Complete dataset inventory

### Expected (from remaining phases)
- `results/blood_signature_25genes.tsv` - Blood signature genes
- `results/blood_tissue_integration_fdr_0.1.tsv` - Cross-dataset integration
- `results/ec_dysfunction_scores.tsv` - EC dysfunction scores
- `results/integrated_features.tsv` - Multi-omics features
- `results/multi_omics_prioritized_genes.tsv` - Prioritized gene list
- `results/pathway_enrichment_fdr_0.1.tsv` - Pathway enrichment results

## 🔧 Installation Status

### Python Packages
- ✅ Core packages installed (pandas, numpy, scipy, sklearn)
- ⚠️  SHAP (optional, for model interpretation)
- ⚠️  scanpy (optional, for single-cell analysis)

### R Packages
- ❌ R not installed
- ⚠️  Required for GSE26969 microarray normalization (affy, Biobase)
- **Note**: Pipeline continues without R, skipping microarray preprocessing

## 🚀 Quick Start Commands

### Run Individual Phases
```bash
# Phase 2: PRS (already completed)
python build_polygenic_risk_score.py

# Phase 3: Blood Integration
python complete_blood_integration.py

# Phase 4: EC Dysfunction
python endothelial_dysfunction_analysis.py

# Phase 5: Multi-Omics
python multi_omics_integration.py

# Comprehensive Integration
python integrate_all_findings_enhanced.py

# Pathway Enrichment
python pathway_enrichment_analysis.py
```

### Run Complete Pipeline
```bash
python run_complete_project_pipeline.py
```

## 📝 Notes

1. **Long-Running Scripts**: Some integration scripts may take 10-30 minutes
2. **R Installation**: Optional but recommended for microarray analysis
3. **Memory Requirements**: Large datasets may require adequate RAM
4. **Output Files**: Check `results/` directory for all generated files

## 🎯 Next Actions

1. **Continue Pipeline**: Let remaining phases complete
2. **Review Results**: Check generated output files
3. **Install R** (optional): For microarray preprocessing
4. **Run Pathway Analysis**: Complete enrichment analysis
5. **Generate Final Summary**: Create comprehensive results report






